The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
| ||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADICET BIO INC | COM | 007002108 | 15,917 | 1,216,860 | SH | SOLE | 1,216,860 | 0 | 0 | ||
| AFFIMED N V | COM | N01045108 | 47,531 | 6,008,974 | SH | SOLE | 6,008,974 | 0 | 0 | ||
| ARVINAS INC | COM | 04335A105 | 30,406 | 460,000 | SH | SOLE | 460,000 | 0 | 0 | ||
| ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 2,618 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| ATARA BIOTHERAPEUTICS INC | COM | 046513107 | 23,971 | 1,669,293 | SH | SOLE | 1,669,293 | 0 | 0 | ||
| BCTG ACQUISITION CORP | COM | 05492W103 | 2,002 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | ||
| CASI PHARMACEUTICALS INC | COM | 14757U109 | 25,298 | 10,540,715 | SH | SOLE | 10,540,715 | 0 | 0 | ||
| CELLECTAR BIOSCIENCES INC | COM PAR | 15117F500 | 6,559 | 4,074,074 | SH | SOLE | 4,074,074 | 0 | 0 | ||
| CONFORMIS INC | COM | 20717E101 | 12,870 | 13,000,000 | SH | SOLE | 13,000,000 | 0 | 0 | ||
| CONSONANCE HFW ACQUISITION C | UNIT 99/99/9999 | G2445M129 | 9,760 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| CTI BIOPHARMA CORP | COM | 12648L601 | 7,312 | 2,512,800 | SH | SOLE | 2,512,800 | 0 | 0 | ||
| DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 44,567 | 993,912 | SH | SOLE | 993,912 | 0 | 0 | ||
| DEERFIELD HEALTHCARE TECH AC | UNIT 07/16/2025 | 244413209 | 3,010 | 229,800 | SH | SOLE | 229,800 | 0 | 0 | ||
| GAMIDA CELL LTD | SHS | M47364100 | 26,844 | 3,318,207 | SH | SOLE | 3,318,207 | 0 | 0 | ||
| GLOBUS MED INC | CL A | 379577208 | 35,668 | 578,371 | SH | SOLE | 578,371 | 0 | 0 | ||
| HELIX ACQUISITION CORP | COM CL A | G4444C102 | 1,530 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| IMMUNOGEN INC | COM | 45253H101 | 5,701 | 703,790 | SH | SOLE | 703,790 | 0 | 0 | ||
| INFINITY PHARMACEUTICALS INC | COM | 45665G303 | 21,237 | 6,575,000 | SH | SOLE | 6,575,000 | 0 | 0 | ||
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 25,018 | 790,197 | SH | SOLE | 790,197 | 0 | 0 | ||
| JIYA ACQUISITION CORP | COM CL A | 47760M102 | 2,952 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| KEROS THERAPEUTICS INC | COM | 492327101 | 54,792 | 890,209 | SH | SOLE | 890,209 | 0 | 0 | ||
| LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | 26,020 | 896,608 | SH | SOLE | 896,608 | 0 | 0 | ||
| MACROGENICS INC | COM | 556099109 | 78,747 | 2,472,447 | SH | SOLE | 2,472,447 | 0 | 0 | ||
| MEDICUS SCIENCES ACQUISITION | UNIT 99/99/9999 | G5960S116 | 2,955 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 43,716 | 255,203 | SH | SOLE | 255,203 | 0 | 0 | ||
| NKARTA INC | COM | 65487U108 | 18,761 | 570,255 | SH | SOLE | 570,255 | 0 | 0 | ||
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 70,181 | 2,709,709 | SH | SOLE | 2,709,709 | 0 | 0 | ||
| RESEARCH ALLIANCE CORP II | COM CL A | 760873109 | 3,075 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| SILENCE THERAPEUTICS PLC | ADS | 82686Q101 | 5,111 | 222,222 | SH | SOLE | 222,222 | 0 | 0 | ||
| SIO GENE THERAPIES INC | COMMON | 829399104 | 8,316 | 3,186,335 | SH | SOLE | 3,186,335 | 0 | 0 | ||
| SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 88,387 | 1,201,399 | SH | SOLE | 1,201,399 | 0 | 0 | ||
| STEREOTAXIS INC | COM NEW | 85916J409 | 23,578 | 3,508,676 | SH | SOLE | 3,508,676 | 0 | 0 | ||
| TURNING POINT THERAPEUTICS I | COM | 90041T108 | 42,603 | 450,396 | SH | SOLE | 450,396 | 0 | 0 | ||
| UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 93,364 | 558,162 | SH | SOLE | 558,162 | 0 | 0 | ||
| VERASTEM INC | COM | 92337C104 | 27,667 | 11,201,412 | SH | SOLE | 11,201,412 | 0 | 0 | ||